CRP was not in patients with ST-segment elevated myocardial infarction. This study is also indicated for these patients treated with primary percutaneous coronary intervention. 8 Based on these studies, high leukocyte and its subsets counts, even within the normal range, appeared to be not only linked to systemic inflammatory response but also to increased risk of cardiovascular disease and adverse prognosis. Moreover, there is no robust consensus in the clinical practice on the leukocyte range association with CAD. 7, 9 This may be due to a wide range of frequency in subjects at high risk, to the investigated population or to unknown confounding factors. 8 Therefore, there is still a need to investigate the association between the frequency of leukocyte subsets and CAD, in subjects with a different disease status.
Several markers of inflammation and of atherosclerosis have been shown to be predictors of CAD. 10 Multiple inflammatory markers have been evaluated as potential risk factors for the development of CAD and its complication. The inflammatory markers which predict CAD events include C-reactive protein (CRP), interleukin-1 (IL-1), interleukin-6 (IL-6), fibrinogen and tumor necrosis factor-± (TNF-±). 11, 12 The markers of atherosclerosis include ankle arm index (AAI) and aortic pulse wave velocity (aPWV), a marker of arterial stiffness. Combination of measures of inflammation and atherosclerosis might be useful for identification of very high risk in adults. IL-6 might be a better risk discriminator of CAD than CRP in older adults. 12 But these markers are costly and not available at all places as neutrophil lymphocyte ratio (NLR), erythrocyte sedimentation rate (ESR) and total leucocyte count. Recently, the total leukocyte count, elevated ESR and elevated NLR has been the subject of interest in predicting the risk for future cardiovascular events. An elevated NLR and ESR independently indicate an increased long term risk of mortality in patients with stable CAD. 13, 14 In this study, we aimed to investigate relationship between ESR, NLR and leucocyte count with CAD proven with angiography and to establish ESR, NLR and leucocytes count as a useful inflammatory marker in detection of CAD.
Methods:
This case control study was conducted at the Department of Clinical pathology with the Department of Cardiology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Shahbag, Dhaka from March 2014 to February 2015. 134 patients were enrolled in this study; 84 cases were considered as Group I (Patients with CAD) and 50 controls were Group II (Patients without CAD). Patients with coronary artery disease who have e" 50% stenosis, adults (18 years and above) patients, patients of both sexes were included in this study. Recurrent myocardial infarction, patients with congenital cardiac disease as shunt or vascular anomalies, pulmonary hypertension (both primary or secondary), acute or chronic infectious diseases, uncontrolled hypertension, known case of patients with cerebrovascular diseases, patients with documented malignancy, hematological disorders, patients with hepatic and renal impairment were excluded from the study. In this study, 2 ml of blood was collected in EDTA tube from the patients prior to PCI for complete blood count (CBC) were measured by haematology autoanalyzer (SYSMEX 4000i), rechecked manually and NLR was calculated in the Department of Clinical Pathology, BSMMU.
After selection, all the patients were thoroughly informed about the aims, objectives and procedure of the study and were encouraged for their voluntary participation. Then an informed written consent was taken from each subject. A detail personal, medical, occupational, educational and smoking history were recorded in a preformed data schedule and thorough physical examinations were done and documented. Tests done in Dept. of Clinical Pathology: CBC with PBF including total and differential count of WBC, erythrocyte sedimentation rate (ESR) and neutrophil lymphocyte ratio (NLR).
Results:
A total 134 patients were included in the study. 84 cases were considered as Group I (patients with CAD) and 50 controls were Group II (patients without CAD).
The mean age of the patients with CAD (Group I) was 54.73±8.94 years, the mean age of the patients without CAD (Group II) was 53.10±9.47 years. 
Table-III Mean NLR difference between Group-I and Group-II (n=134).

Group-I
Group 
Fig.-2: Determination of sensitivity and specificity of neutrophil lymphocyte ratio (NLR) and Group-I (patients with CAD) by ROC curve:
Table-IV Receiver-operator characteristic (ROC) curve of neutrophil lymphocyte ratio and Group-I (patients with CAD) for prediction of coronary artery disease (CAD).
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Discussion:
Erythrocyte sedimentation rate (ESR), neutrophil lymphocyte ratio (NLR) is the sign of balance between neutrophil and lymphocyte levels in the body and an indicator of systemic inflammation. 15 ESR, NLR is a new predictor for cardiovascular risk and mortality. ESR, NLR and leucocyte count could play an important role in early detection of atherosclerosis and by which we can initiate early treatment. 6 Coronary artery disease occurs at any adult age, but it is the disease of middle and old age. In our study, the mean age of the patients in Group I (patients with CAD) was 54.73 (±8.94) years as compared to 56.59±13.63 years and 58.01±12.9 years, studies done by Assiri AS et al., (2012) and Al-Saif SM et al., (2011). 16, 17 It was 52.0±8.6 years in a study reported by Siddique MA et al., (2010) and 56.6 years by Ullah M et al., (2011) in Bangladesh. 18, 19 There was clear male predominance in Group I (89.28%). In Group II there was 46% male. The difference was statistically significant between the groups (p <0.001). Our study is consistent with findings of study done by Bittencourt C et al., (2014). 20 They also found male predominance. They found that in patients with CAD group, male patient was 61.2% and in the other group male patient was 40%. There was also statistically significant association between the groups (p <0.001). 5, 21, 22, 23 In this study, we found a relation of ESR, NLR with the presence of coronary artery disease. There is no doubt in cardiovascular medical science that atherosclerosis is a chronic inflammatory disease. 24, 25 In our study mean ESR in Group I was 31.07± (18.25) , whereas it was 11.76± (6.20) in Group II. There was statistically significant association between two groups in this regards (p <0.001). Our findings are similar to a study conducted by Sahin S et al., (2013) . 4 They also found higher mean ESR in patients with CAD group (5-120 vs 3-28.0) (p <0.001).
Our study mean total count of WBC in Group I was 9.90 ± (1.91), whereas it was 8.66 ± (1.37) in Group II. There was statistically significant association between two groups in this regards (p <0.001). We found higher total WBC count in CAD positive group (Group I) than CAD negative group (Group II). Sonmez O et al., (2013) also found higher total count WBC in patients with coronary artery disease (p <0.001). 5 In our study mean NLR in Group I was 2.76 (±0.74), whereas it was 1.56 (±0.15) in Group II. There was statistically significant association between two groups in this regards (p <0.001). Our findings are similar to a study conducted by Sahin S et al., (2013). 4 They also found higher mean NLR in patients with CAD group (1.98±0.85 vs 2.69±1.74) (p <0.001). Sonmez O et al., (2013) also found higher mean NLR in patients with coronary artery disease (2.3 vs 1.6) (p <0.001). 5 ESR, NLR can be a useful tool to detect and measure the future prognosis of CAD. In this study, we found a relationship between ESR, NLR and CAD proven with angiography and ESR, NLR as a useful inflammatory marker in detection of CAD.
Limitation:
The main limitation of our study was the small sample size and this was a non-randomized single center study. Patients with exclusion criteria were excluded on the basis of clinical feature. No confirmatory pathological tests were carried out to exclude these patients because of financial resource and time constraint.
Conclusion:
Increased erythrocyte sedimentation rate (ESR) and neutrophil lymphocyte ratio (NLR) is a risk factor for developing coronary thrombosis leading to coronary artery disease (CAD). With the help of ESR, NLR we can take preventive measure and precaution to reduce the risk of coronary artery disease. ESR, NLR is a simple, cost effective, readily available test to predict the risk of CAD and can take extra measure and preventive intervention to prevent CAD.
